clinical usage of aztreonam ( azt ) , a newly synthesized antibiotic which belongs to monobactam , was evaluated for its efficacy and safety in 22 patients aged from 1 month-old to 13 year-5 month-old with bacterial infections and the following results were obtained .
C0004521
aztreonam
C0004623
bacterial infections